Tumor Reduction with Pazopanib in a Patient with Recurrent Lumbar Chordoma.
Maurício Fernando Silva Almeida RibeiroMicelange Carvalho de SousaSamir Abdallah HannaMarcos Vinicius Calfat MaldaunCeci Obara KurimoriLuiz Guilherme Cernaglia Aureliano de LimaRomulo Loss MattediRodrigo Ramella MunhozPublished in: Case reports in oncological medicine (2018)
For this patient with a multiple recurrent chordoma and limited treatment options, pazopanib resulted in sustained clinical benefit following initial tumor reduction.
Keyphrases